Abstract
A discriminant function based on topological descriptors was derived from a training set composed by anticonvulsants of clinical use or in clinical phase of development and compounds with other therapeutic uses. This model was internally and externally validated and applied in the virtual screening of chemical compounds from the Merck Index 13th. Methylparaben (Nipagin), a preservative widely used in food, cosmetics and pharmaceutics, was signaled as active by the discriminant function and tested in mice in the Maximal Electroshock (MES) test (i.p. administration), according to the NIH Program for Anticonvulsant Drug Development. Based on the results of Methylparaben, Propylparaben (Nipasol), another preservative usually used in association with the former, was also tested. Both methyl and propylparaben were found active in mice at doses of 30, 100, and 300 mg/kg. The discovery of the anticonvulsant activities in the MES test of methylparaben and propylparaben might be useful for the development of new anticonvulsant medications, specially considering the well-known toxicological profile of these drugs.
Similar content being viewed by others
References
Frank RG (2003) J Health Econ 22:325
DiMasi JA, Hansen RW, Grabowski HG, (2003) J Health Econ 22:151
Dickson M, Gagnon JP (2004) Discov Med 4:172
Willett P (2006) Drug Discov Today 11:1046
Comission on Epidemiology, Prognosis, International League Against Epilepsy (1993) Epilepsia 34:592
Fisher RS, van Emde Boas W, Blume W, Elger C, Genton P, Lee P, Engel J Jr (2005) Epilepsia 46:470
World Health Organization (2001) Fact sheet no. 165: Aetiogy, epidemiology and prognosis
World Health Organization (2001) Fact sheet no. 265: Mental and neurological disorders
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E (2002) Epilepsy Res 51:31
Mahmoudi N; de Julián-Ortiz JV, Ciceron L, Gálvez J., Mazier D, Danis M, Derouin F, García-Domenech R (2006) J Antimicrob Chemother 75:489
García-García A, Gálvez J, de Julián-Ortiz JV, García-Domenech R, Muñoz C, Guna1 R, Borrás R (2004) J Antimicrob Chemother 53:65
Marrero-Ponce Y, Machado Tugores Y, Pereira DN, Escario JA, Barrio AG, Nogal-Ruiz JJ, Ochoa C, Aran VJ, Martínez-Fernández AR, García-Sánchez RN, Montero-Torres A, Torrens F, Meneses-Marcel A (2005) Curr Drug Discov Technol 2:245
Montero-Torres A, García-Sánchez RM, Machado-Tugores Y, Nogal-Ruiz JJ, Martínez-Fernández AR, Aran VJ, Ochoa C, Meneses-Marcel A, Torrens F (2006) Eur J Med Chem 41:483
Prieto JJ, Talevi A, Bruno-Blanch LE (2006) Mol Divers 10:361
Talevi A, Bellera CL, Castro EA, Bruno-Blanch LE (2006) Drugs Future 31(Suppl. A):XIXth Int Symp Med Chem, p 188
Talevi A, Sella-Cravero M, Castro EA, Bruno-Blanch LE (2007) Bioorg Med Chem Lett 17:1684
Soni MG, Taylor SL, Greenberg NA, Burdock GA (2002) Food Chem Toxicol 40:1335
Soni MG, Burdock GA, Taylor SL, Greenberg NA (2001) Food Chem Toxicol 39:513
Talete srl DRAGON for Windows (Software for Molecular Descriptors Calculation) (2003) Version 4.0, http://www.talete.mi.it
National Institute of Statistical Sciences. PowerMV Version 0.61, http://www.niss.org/PowerMV
Statsoft, Inc. STATISTICA (1996) Version 5.1, http://www.statsoft.com
Yasri A, Hartsough D (2001) J Chem Inf Comput Sci 41:1218
Obniska J, Kaminski K, Zagorska A, Dzierzawska-Majewska A, Karolak-Wojciechowska J (2006) J Fluorine Chem 127:417
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Loiseau P, Perucca E (1999) Epilepsy Res 34:1
De Sarro G, Ferreri G, Gareri P, Russo E, De Sarro A, Gitto R, Chimirri A (2003) Pharmacol Biochem Behav 74:595
Ferreri G, Chimirri A, Russo E, Gitto R, Gareri P, De Sarro A, De Sarro G (2004) Pharmacol Biochem Behav 77:85
Obniska J, Jurczyk S, Zejc A, Kaminski K, Tatarczynska E, Stachowicz K (2005) Pharmacol Rep 57:170
Schenck HA, Lenkowski PW, Choudhury-Mukherjee I, Ko S, Stables JP, Patel MK, Brown ML (2004) Bioorg Med Chem 12:979
Beguin C, LeTiran A, Stables JP, Voyksner RD, Kohn H (2004) Bioorg Med Chem 12:3079
Kaymakçıoğlu B, Rollas S, Körceğez E, Arıcıoğlu F (2005) Eur J Pharm Sci 26:97
Gálvez J, García-Domenech C, de Alapont G, de Julián-Ortiz JV, Popa L (1996) J Mol Graph 14:272
The Merck Index (2001) Encyclopedia of chemicals, drugs and biologicals, 13th edn. Merck and Co. Withehouse Station, New Jersey
Stables JP, Kupferberg HJ, Gladding R (1997) In: Avanzini G, Regesta G, Tanganelli P, Avoli M (eds) Molecular and cellular targets for antiepileptic drugs, John Libbey & Company Ltd., London, England, pp 191–198
Raychaudhury C, Ray SK, Ghosh JJ, Roy AB, Basak SC (1984) J Comput Chem 5:581
Magnuson DR, Harris VK, Basak SC (1983) In: King RB (ed) Studies in physical and theoretical chemistry. Elsevier, Amsterdam, Netherlands, pp 178–191
Geary RC (1954) Incorp Stat 5:115
Basak SC (1999) In: Devillers J, Balaban AT (eds) Topological indices and related descriptors in QSAR and QSPR. Gordon and Breach Science Publishers, Amsterdam, pp 563–593
Srivasta AK, Gupta YK (2001) Indian J Physiol Pharmacol 45:475
Walil RS, Patil PA (1995) Indian J Physiol Pharmacol 39:77
Bubnoff MV, Schnell D, Vogt-Mycoff J (1957) Arzeimittel Forschung 7:340
SciFinder Chemical Abstracts Service (American Chemical Society) (2006) Bibliographic database. http://www.cas.org/SCIFINDER/
Levy RH, Dreifuss FE, Mattson RH, Meldrum BS, Kiffin Penry J (1989) Antiepileptic drugs. Raven Press, New York
Acknowledgments
We want to thank Guillermina Estiú (University of Notre Dame) and Luciana Gavernet for their valuable help in bibliographic search and Rubén Greco for his valuable assistance in biological tests. A. Talevi thanks CONICET for his Type I Post grade Fellowship. E.A. Castro is a member of CONICET. L.E. Bruno-Blanch thanks the Facultad de Ciencias Exactas de la Universidad Nacional de La Plata (Incentivos UNLP) and the Agencia Nacional de Promoción Científica y Tecnológica (PICT BIB 1728/06-11985).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Talevi, A., Bellera, C.L., Castro, E.A. et al. A successful virtual screening application: prediction of anticonvulsant activity in MES test of widely used pharmaceutical and food preservatives methylparaben and propylparaben. J Comput Aided Mol Des 21, 527–538 (2007). https://doi.org/10.1007/s10822-007-9136-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10822-007-9136-9